Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

BIOABIOA
5 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in BIOAGE LABS INC

Yes. Jacobs Levy Equity Management holds 377,085 shares of BIOA (Bioage Labs), worth $9.2M, as of its Q2 2026 13F filing. It reduced the position by 43,038 shares (-10.2%) from Q1 2026. Jacobs Levy Equity Management has held BIOA since Q2 2025, across 5 quarterly 13F filings.

Current Value

$9.2M

Current Shares

377,085

Total Value Change

+$8.1M

Total Shares Change

+103,633

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
377,085
-10.2%
$9.2M0.0%$24.51
0
2026-Q1
Increased
420,123
+25.7%
$7.3M0.0%$20.46
34
2025-Q4
Increased
334,126
+56.8%
$4.4M0.0%$13.63
38
2025-Q3
Decreased
213,088
-22.1%
$1.3M0.0%$5.45
0
2025-Q2
New
273,452
-
$1.1M0.0%$4.20
35

Other major holders of BIOA: BlackRock, Inc., Jupiter Topco LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used